Oxymorphone Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Grow Your Pharma Business Digitally

X

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Oxymorphone Hydrochloride
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Oxymorphone Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 8 USDMF, 4 NDC API, 6 Listed Suppliers

11 API Suppliers
8 USDMF
4 NDC API
6 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

75 FDF Dossiers, 75 FDA Orange Book

75 FDF Dossiers
75 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 1MG/ML, TABLET, EXTENDED RELEASE;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 15MG, TABLET, EXTENDED RELEASE;ORAL - 20MG, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 5MG, TABLET, EXTENDED RELEASE;ORAL - 7.5MG, TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 1MG/ML
TABLET, EXTENDED RELEASE;ORAL - 10MG
TABLET, EXTENDED RELEASE;ORAL - 15MG
TABLET, EXTENDED RELEASE;ORAL - 20MG
TABLET, EXTENDED RELEASE;ORAL - 30MG
TABLET, EXTENDED RELEASE;ORAL - 40MG
TABLET, EXTENDED RELEASE;ORAL - 5MG
TABLET, EXTENDED RELEASE;ORAL - 7.5MG
TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

15 News #PharmaBuzz

15 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 17 Regulatory FDF Prices

1 US Medicaid Prescriptions
17 Regulatory FDF Prices

PATENTS & EXCLUSIVITIES

42 US Patents

42 US Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

42 All

01 14ENDO OPERATIONS

02 28ENDO PHARMS

filter Patent Number Reset all filters

42 All

01 77851482

02 78192722

03 148808737

04 148871779

filter API Patent Reset all filters

42 All

01 21Y

02 21Blank

filter FDF Patent Reset all filters

42 All

01 7Y

02 35Blank

filter Expiration Date Reset all filters

42 All

01 72025-09-15

02 142027-06-21

03 72029-07-10

04 142029-11-22

Product Main Page

01

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-21

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8808737

Drug Substance Claim :

Drug Product Claim :

Application Number : 201655

Patent Use Code : U-1598

Delist Requested :

Patent Use Description : METHOD OF ADMINISTRATI...

Patent Expiration Date : 2027-06-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-21

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8808737

Drug Substance Claim :

Drug Product Claim :

Application Number : 201655

Patent Use Code : U-1598

Delist Requested :

Patent Use Description : METHOD OF ADMINISTRATI...

Patent Expiration Date : 2027-06-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-21

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8808737

Drug Substance Claim :

Drug Product Claim :

Application Number : 201655

Patent Use Code : U-1598

Delist Requested :

Patent Use Description : METHOD OF ADMINISTRATI...

Patent Expiration Date : 2027-06-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-21

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8808737

Drug Substance Claim :

Drug Product Claim :

Application Number : 201655

Patent Use Code : U-1598

Delist Requested :

Patent Use Description : METHOD OF ADMINISTRATI...

Patent Expiration Date : 2027-06-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-21

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8808737

Drug Substance Claim :

Drug Product Claim :

Application Number : 201655

Patent Use Code : U-1598

Delist Requested :

Patent Use Description : METHOD OF ADMINISTRATI...

Patent Expiration Date : 2027-06-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-21

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8808737

Drug Substance Claim :

Drug Product Claim :

Application Number : 201655

Patent Use Code : U-1598

Delist Requested :

Patent Use Description : METHOD OF ADMINISTRATI...

Patent Expiration Date : 2027-06-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-21

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8808737

Drug Substance Claim :

Drug Product Claim :

Application Number : 201655

Patent Use Code : U-1598

Delist Requested :

Patent Use Description : METHOD OF ADMINISTRATI...

Patent Expiration Date : 2027-06-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-09-15

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8192722

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201655

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-07-10

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 7851482

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 201655

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-07-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

ENDO PHARMS

OXYMORPHONE HYDROCHLORIDE

ELCC

Not Confirmed

ENDO PHARMS

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-11-22

OXYMORPHONE HYDROCHLORIDE

US Patent Number : 8871779

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 201655

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-11-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!